PEN – Penumbra, Inc.

Penumbra, Inc.

PEN

$291.68

Name : Penumbra, Inc.

Sector : Healthcare

Industry: Medical Devices

Mark. Cap: $11,234,317,312.00

EPSttm : 0.35

Penumbra, Inc.

$291.68

3.77%

$11.44

Float Short %

3.86

Margin Of Safety %

-27

Put/Call OI Ratio

0.14

EPS Next Q Diff

-0.12

EPS Last/This Y

EPS This/Next Y

1.27

Price

291.75

Target Price

307.71

Analyst Recom

1.6

Performance Q

21.29

Relative Volume

1.47

Beta

0.52

Ticker: PEN

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-01-23	PEN	273.48	0.05	0.07	9321
2025-01-24	PEN	274.02	0.05	0.56	8874
2025-01-27	PEN	272.93	0.05	0.76	9908
2025-01-28	PEN	270.9	0.05	0.25	9935
2025-01-29	PEN	269.54	0.05	0.80	9946
2025-01-30	PEN	269.1	0.05	3.00	9955
2025-01-31	PEN	266.82	0.05	1.25	9961
2025-02-03	PEN	264.89	0.05	0.50	9961
2025-02-04	PEN	262.1	0.06	0.04	9990
2025-02-05	PEN	266.02	0.05	0.57	10155
2025-02-06	PEN	261.38	0.06	0.32	10190
2025-02-07	PEN	260.74	0.06	0.37	10208
2025-02-10	PEN	261.04	0.06	0.83	10219
2025-02-11	PEN	268.84	0.06	0.02	10226
2025-02-12	PEN	267.59	0.06	0.00	10323
2025-02-13	PEN	273.05	0.05	14.74	11414
2025-02-14	PEN	268.4	0.10	2.09	11924
2025-02-18	PEN	270.99	0.11	0.39	12181
2025-02-19	PEN	303.71	0.13	0.08	12928
2025-02-20	PEN	303.17	0.14	0.48	13181
2025-02-21	PEN	291.76	0.14	0.06	13187
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-01-23	PEN	273.78	17.6	159.5	2.79
2025-01-24	PEN	274.03	17.6	161.0	2.79
2025-01-27	PEN	272.80	17.6	160.0	2.79
2025-01-28	PEN	271.17	17.6	159.8	2.79
2025-01-29	PEN	269.62	17.6	160.0	2.79
2025-01-30	PEN	269.00	17.6	160.4	2.79
2025-01-31	PEN	266.86	17.6	159.4	2.79
2025-02-03	PEN	265.00	17.6	159.5	2.79
2025-02-04	PEN	262.18	17.6	158.9	2.79
2025-02-05	PEN	265.45	17.6	162.1	2.79
2025-02-06	PEN	261.43	17.6	157.8	2.79
2025-02-07	PEN	260.78	17.6	160.3	2.79
2025-02-10	PEN	261.05	17.6	161.1	2.79
2025-02-11	PEN	268.72	17.6	166.1	2.79
2025-02-12	PEN	267.35	17.6	160.2	2.79
2025-02-13	PEN	272.89	17.6	164.7	2.79
2025-02-14	PEN	268.67	17.6	158.1	2.79
2025-02-18	PEN	271.05	17.6	162.4	2.79
2025-02-19	PEN	303.76	17.6	182.3	2.79
2025-02-20	PEN	303.18	64.6	154.4	3.66
2025-02-21	PEN	291.75	64.6	156.7	3.66
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-01-23	PEN	-6.82	-0.59	4.96
2025-01-24	PEN	-6.82	-0.59	4.96
2025-01-27	PEN	-6.82	-0.59	4.96
2025-01-28	PEN	-6.82	-0.59	5.05
2025-01-29	PEN	-6.82	-0.59	5.05
2025-01-30	PEN	-6.82	-0.59	5.05
2025-01-31	PEN	-6.82	-0.59	5.06
2025-02-03	PEN	-6.68	-0.29	5.05
2025-02-04	PEN	-6.82	-0.29	5.05
2025-02-05	PEN	-6.82	-0.29	5.05
2025-02-06	PEN	-6.82	-0.29	5.05
2025-02-07	PEN	-6.82	-0.29	5.05
2025-02-10	PEN	-6.82	0.49	5.06
2025-02-11	PEN	-6.69	0.49	5.06
2025-02-12	PEN	-6.69	0.49	3.87
2025-02-13	PEN	-6.69	0.49	3.87
2025-02-14	PEN	-6.76	0.49	3.87
2025-02-18	PEN	-6.73	-0.44	3.87
2025-02-19	PEN	-6.73	-0.44	3.87
2025-02-20	PEN	-6.73	-0.44	3.87
2025-02-21	PEN	-6.70	-0.44	3.86
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

0.97

Avg. EPS Est. Current Quarter

0.67

Avg. EPS Est. Next Quarter

0.85

Insider Transactions

-6.7

Institutional Transactions

-0.44

Beta

0.52

Average Sales Estimate Current Quarter

315

Average Sales Estimate Next Quarter

332

Fair Value

214.25

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

16.3

Max Drawdown 5-Year %

-62.6

Target Price

307.71

P/E

847.91

Forward P/E

59.16

PEG

20.98

P/S

9.4

P/B

9.75

P/Free Cash Flow

76.27

EPS

0.34

Average EPS Est. Cur. Y

3.66

EPS Next Y. (Est.)

4.94

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

1.17

Relative Volume

1.47

Return on Equity vs Sector %

-18

Return on Equity vs Industry %

-10.9

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.13

EBIT Estimation

156.7

Penumbra, Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 4500

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

stock quote shares PEN – Penumbra, Inc. Stock Price stock today

news today PEN – Penumbra, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch PEN – Penumbra, Inc. yahoo finance google finance

stock history PEN – Penumbra, Inc. invest stock market

stock prices PEN premarket after hours

ticker PEN fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

PEN – Penumbra, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: PEN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y